Vaccines including but not limited to: hepatitis a, hepatitis b, combined hepatitis a and b, MMR measles, mumps, rubella, TD tetanus, diphtheria, tdap tetanus, diphtheria and pertussis, meningitis,…
Ended Awarded Last action
- Contract number
- 15F06723F0000397
- Awardee
-
Valneva Usa, Inc. UEI NT38AFWQNKM7
- Awarding agency
-
Headquarters Division
Federal Bureau of Investigation, Department of Justice
- Obligated
- $62,179
Award facts
- Contract value 100% obligated
- $62,179.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20814, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$7,821 | |
| Original award | $70,000 |
About this award
This is a federal contract award to Valneva USA, Inc. (doing business as Intercell USA Inc.), a specialty vaccine company, by the U.S. Department of Justice. The award, valued at $62,179.00, is for the delivery of various vaccines, including but not limited to hepatitis A, hepatitis B, measles-mumps-rubella (MMR), tetanus-diphtheria (Td), and meningitis, among others. This is a Blanket Purchase Agreement (BPA) call order, with a firm fixed price pricing type and an ultimate completion date of September 30, 2023. The contract does not have a set-aside designation. Valneva USA, Inc. is the prime contractor and there are no major subcontractors mentioned. This award is part of a larger Indefinite Delivery/Indefinite Quantity (IDIQ) contract vehicle with the Federal Bureau of Investigation (FBI) to supply critical vaccines, supporting the agency's health and safety initiatives.
Description
Vaccines including but not limited to: hepatitis a, hepatitis b, combined hepatitis a and b, MMR measles, mumps, rubella, TD tetanus, diphtheria, tdap tetanus, diphtheria and pertussis, meningitis, rabies, polio, typhoid injectable and oral, yellow f
Quick answers
Who was awarded contract 15F06723F0000397?
15F06723F0000397 was awarded to Valneva Usa, Inc. by Headquarters Division (Federal Bureau of Investigation) on January 31, 2022.
How much is contract 15F06723F0000397 worth?
The government has obligated $62,179 on 15F06723F0000397.
Is contract 15F06723F0000397 an order under another contract?
Yes. 15F06723F0000397 is a BPA call under 15F06720A0000540, a blanket purchase agreement.
Was contract 15F06723F0000397 competed?
The extent of competition for 15F06723F0000397 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award